UK Stocks-Factors to watch on September 29

By Reuters News

- Britain's FTSE 100 .FTSE index is seen opening higher on Tuesday, with futures up 0.1%.

* ASTRAZENECA: AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up. Separately, HUTCHMED (China) said that AstraZeneca had applied to the US FDA for approval of the ORPATHYS-TAGRISSO combination to treat patients with advanced lung cancer.

* INFLATION: British shop price inflation slowed slightly in September despite rising cost pressures on retailers from the Iran war, according to a survey from the British Retail Consortium, which urged the government to do more to help.

* ENERGY: Andy Burnham will announce plans to create Great British Grid, a publicly owned body within Great British Energy, during his Labour Party conference speech, the party said on Monday.

* OIL: Oil prices rose for a second successive session as concern over Middle East supply disruption from the US-Iran conflict outweighed signs of recovering crude exports from the region.

* GOLD: Gold inched up but hovered near a more than seven-week low as concerns that the Federal Reserve may keep interest rates higher for longer outweighed investor focus on upcoming US economic data.

* METALS: Copper advanced after a sharp selloff in the previous session, even as a strong dollar, elevated oil prices and concerns about Chinese demand kept a cap on bullish sentiment.

* The UK blue-chip index .FTSE closed down 0.10% on Monday as weaker metal prices and rising bond yields kept risk appetite in check.

* UK CORPORATE DIARY:

Close Brothers

CBRO.L

FY results

S&U PLC

SUS.L

HY results

A.G. Barr

BAG.L

HY results

Card Factory

CARDC.L

HY results

* For more on the factors affecting European stocks, please click on: LIVE/

TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk